TILC - ETF AI Analysis
Top Page
Thrivent International Large Cap ETF (TILC)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Several of the largest positions, including ASML and Tokyo Electron, have shown strong recent performance, helping support the ETF’s returns.
Broad International Diversification
The fund spreads its assets across many developed markets such as Japan, the UK, France, and others, reducing reliance on any single country.
Balanced Sector Mix
Exposure across financials, industrials, technology, health care, and other sectors helps smooth out the impact of weakness in any one industry.
Negative Factors
Moderate Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can slightly reduce long-term net returns compared with lower-cost options.
Concentrated Country Exposure
A large share of assets is concentrated in a few countries like Japan and the UK, which can increase the impact of economic or political issues in those markets.
Mixed Performance Among Top Holdings
While some top positions have been strong, others like Roche have been weak, which can create uneven overall performance.
TILC vs. SPDR S&P 500 ETF (SPY)
AUM833.47M
RegionDeveloped Markets
Expense Ratio0.52%
BetaN/A
IssuerThrivent
Inception DateJun 15, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume349
30 Day Avg. Volume311
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
27.83Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering300
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TILC Summary
Thrivent International Large Cap ETF (TILC) is an exchange-traded fund that invests in large, well-established companies outside the United States, aiming for long-term growth. It does not track a specific index, but follows a theme of broad international large-cap stocks across countries like Japan, the UK, France, and Australia, and sectors such as financials, industrials, and technology. Well-known holdings include ASML Holding and Novartis. Investors might consider TILC to diversify beyond U.S. stocks and gain overseas growth potential. A key risk is that international markets and currencies can be volatile, so the ETF’s value can go up and down significantly.
How much will it cost me?This ETF has an expense ratio of 0.52%, which means you’ll pay about $5.20 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is actively managed, which typically involves more research and trading.
What would affect this ETF?This ETF could benefit if developed markets outside the U.S. grow steadily, especially in areas like technology, health care, and industrials where top holdings such as ASML, Novartis, and ABB operate, and if global trade and energy demand support companies like BHP and Shell. On the other hand, slower economic growth abroad, rising interest rates that pressure financial firms like Allianz and BNP Paribas, currency swings, or geopolitical tensions in Europe or Asia could hurt returns for this international large-cap fund.
TILC Top 10 Holdings
TILC leans heavily on international heavyweights, with chip-equipment leaders ASML and Tokyo Electron doing much of the heavy lifting as they ride a strong upswing in global semiconductor demand. Industrial name ABB and miner BHP are also rising, giving the fund an extra boost from Europe and Australia. On the flip side, health care giant Roche has been lagging, and Shell’s recent softness has kept energy from pulling its full weight. Overall, the ETF is tilted toward developed markets in Europe and Asia, with notable strength in tech and industrials.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.58% | $30.20M | €633.25B | 151.49% | 76 Outperform | |
| Novartis AG | 2.18% | $18.39M | CHF215.97B | 26.50% | 80 Outperform | |
| ABB Ltd | 2.03% | $17.17M | kr1.86T | 87.78% | 78 Outperform | |
| Allianz | 1.90% | $16.06M | €151.63B | 19.27% | 67 Neutral | |
| BHP Group Ltd | 1.81% | $15.30M | AU$311.95B | 75.44% | 68 Neutral | |
| Shell (UK) | 1.65% | $13.92M | £166.17B | 12.09% | 73 Outperform | |
| BNP Paribas | 1.53% | $12.95M | €112.21B | 37.70% | 77 Outperform | |
| Roche Holding AG | 1.48% | $12.50M | $315.55B | 23.56% | 73 Outperform | |
| GlaxoSmithKline | 1.43% | $12.12M | £77.17B | 37.17% | 77 Outperform | |
| Investor AB | 1.40% | $11.79M | kr1.19T | 43.01% | 77 Outperform |
TILC Technical Analysis
Negative
―
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TILC, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TILC.
TILC Peer Comparison
Comparison Results
Performance Comparison
TILC
Thrivent International Large Cap ETF
25.01
-0.37
-1.46%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
AVSD
Avantis Responsible International Equity ETF
―
―
―
NBIE
Neuberger International Core Equity ETF
―
―
―
TLCI
Touchstone International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents